Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Squires

Showing results (71-80 of 81) with videos related to

Pageof 9
Sort By:
International Journal of Radiation Oncology, Biology, Physics|January 14, 2020
Mapping of Metastatic Level I Axillary Lymph Nodes in Patients with Newly Diagnosed Breast CancerMuayad F Almahariq, Michael J Maywood, Ronald B Levitin, et al.
International Journal of Molecular Sciences|August 14, 2013
Structural variations in articular cartilage matrix are associated with early-onset osteoarthritis in the spondyloepiphyseal dysplasia congenita (sedc) mouseDavid W Macdonald, Ryan S Squires, Shaela A Avery, et al.
Neuro-Oncology Practice|August 9, 2020
Predictors of radiation necrosis in long-term survivors after Gamma Knife stereotactic radiosurgery for brain metastasesZaid A Siddiqui, Bryan S Squires, Matt D Johnson, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 18, 2011
A phase I pharmacokinetic and pharmacodynamic study of AT7519, a cyclin-dependent kinase inhibitor in patients with refractory solid tumorsD Mahadevan, R Plummer, M S Squires, et al.
Biochemical Pharmacology|January 16, 2003
Relevance of mitogen activated protein kinase (MAPK) and phosphotidylinositol-3-kinase/protein kinase B (PI3K/PKB) pathways to induction of apoptosis by curcumin in breast cellsMatthew S Squires, E Ann Hudson, Lynne Howells, et al.
Journal of Cardiovascular Pharmacology|July 29, 2022
Hypersensitivity of Zebrafish htr2b Mutant Embryos to Sertraline Indicates a Role for Serotonin Signaling in Cardiac DevelopmentMitchell E Kent, Bo Hu, Timothy M Eggleston, et al.
Leukemia Research|February 15, 2011
Comparative pre-clinical evaluation of receptor tyrosine kinase inhibitors for the treatment of multiple myelomaLuis R de Brito, Mike A Batey, Yan Zhao, et al.
Blood|June 16, 2010
Activity of the multitargeted kinase inhibitor, AT9283, in imatinib-resistant BCR-ABL-positive leukemic cellsRuriko Tanaka, Matthew S Squires, Shinya Kimura, et al.
Advances in Radiation Oncology|July 26, 2023
Near-Surface Dose Correlates With Moist Desquamation and Unplanned Reconstructive Surgery in Patients With Implant-Based Reconstruction Receiving Postmastectomy Radiation TherapyRonald Levitin, Kamran Salari, Bryan S Squires, et al.
British Journal of Haematology|May 29, 2010
AT9283, a potent inhibitor of the Aurora kinases and Jak2, has therapeutic potential in myeloproliferative disordersMark A Dawson, Jayne E Curry, Kelly Barber, et al.
Pageof 9

Showing results (71-80 of 81) with videos related to

Sort By:
Pageof 9
International Journal of Radiation Oncology, Biology, Physics|January 14, 2020
Mapping of Metastatic Level I Axillary Lymph Nodes in Patients with Newly Diagnosed Breast CancerMuayad F Almahariq, Michael J Maywood, Ronald B Levitin, et al.
International Journal of Molecular Sciences|August 14, 2013
Structural variations in articular cartilage matrix are associated with early-onset osteoarthritis in the spondyloepiphyseal dysplasia congenita (sedc) mouseDavid W Macdonald, Ryan S Squires, Shaela A Avery, et al.
Neuro-Oncology Practice|August 9, 2020
Predictors of radiation necrosis in long-term survivors after Gamma Knife stereotactic radiosurgery for brain metastasesZaid A Siddiqui, Bryan S Squires, Matt D Johnson, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 18, 2011
A phase I pharmacokinetic and pharmacodynamic study of AT7519, a cyclin-dependent kinase inhibitor in patients with refractory solid tumorsD Mahadevan, R Plummer, M S Squires, et al.
Biochemical Pharmacology|January 16, 2003
Relevance of mitogen activated protein kinase (MAPK) and phosphotidylinositol-3-kinase/protein kinase B (PI3K/PKB) pathways to induction of apoptosis by curcumin in breast cellsMatthew S Squires, E Ann Hudson, Lynne Howells, et al.
Journal of Cardiovascular Pharmacology|July 29, 2022
Hypersensitivity of Zebrafish htr2b Mutant Embryos to Sertraline Indicates a Role for Serotonin Signaling in Cardiac DevelopmentMitchell E Kent, Bo Hu, Timothy M Eggleston, et al.
Leukemia Research|February 15, 2011
Comparative pre-clinical evaluation of receptor tyrosine kinase inhibitors for the treatment of multiple myelomaLuis R de Brito, Mike A Batey, Yan Zhao, et al.
Blood|June 16, 2010
Activity of the multitargeted kinase inhibitor, AT9283, in imatinib-resistant BCR-ABL-positive leukemic cellsRuriko Tanaka, Matthew S Squires, Shinya Kimura, et al.
Advances in Radiation Oncology|July 26, 2023
Near-Surface Dose Correlates With Moist Desquamation and Unplanned Reconstructive Surgery in Patients With Implant-Based Reconstruction Receiving Postmastectomy Radiation TherapyRonald Levitin, Kamran Salari, Bryan S Squires, et al.
British Journal of Haematology|May 29, 2010
AT9283, a potent inhibitor of the Aurora kinases and Jak2, has therapeutic potential in myeloproliferative disordersMark A Dawson, Jayne E Curry, Kelly Barber, et al.
Pageof 9